LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,338 | 44,169 | 46,668 | 46,765 | 45,888 |
| Marketable Securities | 323 | 390 | 0 | N/A | N/A |
| Receivables | 5,927 | 5,729 | 8,610 | 8,793 | 8,596 |
| Inventories | 8,299 | 7,113 | 6,281 | 6,094 | 5,481 |
| TOTAL | $66,361 | $62,919 | $67,315 | $65,915 | $65,166 |
| Non-Current Assets | |||||
| PPE Net | 65 | 88 | 113 | 140 | 163 |
| Intangibles | 32,668 | 33,056 | 33,444 | 33,832 | 34,220 |
| Other Non-Current Assets | 272 | 315 | 358 | 407 | 459 |
| TOTAL | $33,005 | $33,459 | $33,915 | $34,379 | $34,842 |
| Total Assets | $99,366 | $96,378 | $101,230 | $100,294 | $100,008 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,125 | 2,789 | 2,278 | 2,314 | 1,846 |
| Accrued Expenses | 11,362 | 10,254 | 10,029 | 13,521 | 14,087 |
| Other current liabilities | N/A | N/A | 2,325 | N/A | N/A |
| TOTAL | $16,493 | $16,048 | $17,635 | $15,995 | $16,101 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,849 | 2,849 | 2,849 | N/A | N/A |
| Other Non-Current Liabilities | 27,805 | 26,305 | 25,830 | 28,220 | 26,880 |
| TOTAL | $152,341 | $150,824 | $150,333 | $152,707 | $151,350 |
| Total Liabilities | $168,834 | $166,872 | $167,968 | $168,702 | $167,451 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,937 | 25,556 | 25,962 | 27,524 | 27,488 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -1,054,632 | -1,057,090 | -1,057,092 | -1,060,861 | -1,058,601 |
| Other shareholders' equity | 3,907 | 3,906 | 3,907 | 3,906 | 3,906 |
| TOTAL | $-69,468 | $-70,494 | $-66,738 | $-68,408 | $-67,443 |
| Total Liabilities And Equity | $99,366 | $96,378 | $101,230 | $100,294 | $100,008 |